MTHFD2- a new twist?
نویسندگان
چکیده
Rapidly proliferating tumors attempt to meet the demands for nucleotide biosynthesis by up-regulating folate pathways that provide the building blocks for pyrimidine and purine biosynthesis. Reduced folates are carriers of one carbon units required for the synthesis of purines, thymidylate and methionine, derived from serine, glycine and formate. As folate metabolism plays a key role in cell proliferation, the folate-requiring enzymes dihydrofolate reductase and thymidylate synthase have long been key targets for treatment of cancer. Recent studies show that the mitochondrial folate enzymes are also critical, in that they enable mitochondria to produce additional one carbon units for purine synthesis to allow for rapid growth. In transformed cells, methylene tetrahydrofolate dehydrogenase MTHFD2 is often reactivated and expressed along with other members of the serine synthesis, one carbon (folate) metabolism and glycine cleavage system, allowing for enhanced production of purines, ATP and NADPH, fueling cell proliferation [1]. More recently, it has been recognized that these enzymes are critical for the generation of NADH/NADPH, necessary for protection from ROS and required for macromolecular synthesis. MTHFD2 is a bifunctional enzyme with methylene dehydrogenase and cyclohydrolase activity that produces N-10 formyl tetrahydrofolate, the source of C2 and C8 in purines and NADH from methylenetetrahydrofolate and NAD [2]. The cytoplasmic enzyme, MTHFD1 uses NADP as a cofactor as compared to MTHFD2, which carries out the same enzyme activity using NAD, Mg++ and PO4-. In rapidly growing cancer cells, but not normal proliferating cells, MTHFD2 is the major source of formate for purine synthesis (Figure 1). Using gene expression arrays, we have shown that overexpression of mitochondrial enzymes, particularly MTHFD2, is associated with both high proliferation rates and cMYC overexpression [3]; this key role for MTHFD2 in cancer cell proliferation has recently been confirmed [4]. Most importantly, overexpression of MTHFD2 has been shown to be associated with poor prognosis of patients with breast cancer [5] and with an increased rate of invasion and metastasis [6]. That MTHFD2: 1) is over expressed in rapidly replicating tumor cells but not in adult tissue, and 2) enhances tumor cell proliferation provides a strong rationale for targeting this enzyme for selective cancer treatment [7].
منابع مشابه
Targeting MTHFD2 in acute myeloid leukemia
Drugs targeting metabolism have formed the backbone of therapy for some cancers. We sought to identify new such targets in acute myeloid leukemia (AML). The one-carbon folate pathway, specifically methylenetetrahydrofolate dehydrogenase-cyclohydrolase 2 (MTHFD2), emerged as a top candidate in our analyses. MTHFD2 is the most differentially expressed metabolic enzyme in cancer versus normal cell...
متن کاملSimulation of a New Process Design to Fabricate a Rectangular Twist Waveguide Using Extrusion and a Twist Die
The aim of the present study is to determine the feasibility of making a rectangular twist waveguide used to rotate electromagnetic waves. For this purpose, the process of fabricating an aluminum rectangular twist waveguide was simulated by making use of finite element method and Deform software. The optimum length and angle of the twist die for manufacturing a twist waveguide with inner cross ...
متن کاملMitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.
Rapidly proliferating tumors attempt to meet the demands for nucleotide biosynthesis by upregulating folate pathways that provide the building blocks for pyrimidine and purine biosynthesis. In particular, the key role of mitochondrial folate enzymes in providing formate for de novo purine synthesis and for providing the one-carbon moiety for thymidylate synthesis has been recognized in recent s...
متن کاملMetabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
Metabolic remodeling is now widely regarded as a hallmark of cancer, but it is not clear whether individual metabolic strategies are frequently exploited by many tumours. Here we compare messenger RNA profiles of 1,454 metabolic enzymes across 1,981 tumours spanning 19 cancer types to identify enzymes that are consistently differentially expressed. Our meta-analysis recovers established targets...
متن کاملSuppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
Methylenetetrahydrofolate dehydrogenase (NAD(P)+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2) is a mitochondrial enzyme involved in folate metabolism. A number of recent studies have highlighted this enzyme as being highly expressed in many solid tumors, including breast cancer, and to be correlated with poor survival. However, the metabolic functions of MTHFD2 in cancer cells...
متن کامل